Copyright Reports & Markets. All rights reserved.

Global Non-oncology Biopharmaceuticals Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biologics
      • 1.4.3 Biosimilars
    • 1.5 Market by Application
      • 1.5.1 Global Non-oncology Biopharmaceuticals Market Share by Application (2014-2025)
      • 1.5.2 Immunology
      • 1.5.3 Endocrinology
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Non-oncology Biopharmaceuticals Market Size
    • 2.2 Non-oncology Biopharmaceuticals Growth Trends by Regions
      • 2.2.1 Non-oncology Biopharmaceuticals Market Size by Regions (2014-2025)
      • 2.2.2 Non-oncology Biopharmaceuticals Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Non-oncology Biopharmaceuticals Market Size by by Players
      • 3.1.1 Global Non-oncology Biopharmaceuticals Revenue by by Players (2014-2019)
      • 3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Non-oncology Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
    • 3.2 Non-oncology Biopharmaceuticals Key Players Head office and Area Served
    • 3.3 Key Players Non-oncology Biopharmaceuticals Product/Solution/Service
    • 3.4 Date of Enter into Non-oncology Biopharmaceuticals Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Non-oncology Biopharmaceuticals Market Size by Type (2014-2019)
    • 4.2 Global Non-oncology Biopharmaceuticals Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 5.2 Non-oncology Biopharmaceuticals Key Players in United States
    • 5.3 United States Non-oncology Biopharmaceuticals Market Size by Type
    • 5.4 United States Non-oncology Biopharmaceuticals Market Size by Application

    6 Europe

    • 6.1 Europe Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 6.2 Non-oncology Biopharmaceuticals Key Players in Europe
    • 6.3 Europe Non-oncology Biopharmaceuticals Market Size by Type
    • 6.4 Europe Non-oncology Biopharmaceuticals Market Size by Application

    7 China

    • 7.1 China Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 7.2 Non-oncology Biopharmaceuticals Key Players in China
    • 7.3 China Non-oncology Biopharmaceuticals Market Size by Type
    • 7.4 China Non-oncology Biopharmaceuticals Market Size by Application

    8 Japan

    • 8.1 Japan Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 8.2 Non-oncology Biopharmaceuticals Key Players in Japan
    • 8.3 Japan Non-oncology Biopharmaceuticals Market Size by Type
    • 8.4 Japan Non-oncology Biopharmaceuticals Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 9.2 Non-oncology Biopharmaceuticals Key Players in Southeast Asia
    • 9.3 Southeast Asia Non-oncology Biopharmaceuticals Market Size by Type
    • 9.4 Southeast Asia Non-oncology Biopharmaceuticals Market Size by Application

    10 India

    • 10.1 India Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 10.2 Non-oncology Biopharmaceuticals Key Players in India
    • 10.3 India Non-oncology Biopharmaceuticals Market Size by Type
    • 10.4 India Non-oncology Biopharmaceuticals Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Non-oncology Biopharmaceuticals Market Size (2014-2019)
    • 11.2 Non-oncology Biopharmaceuticals Key Players in Central & South America
    • 11.3 Central & South America Non-oncology Biopharmaceuticals Market Size by Type
    • 11.4 Central & South America Non-oncology Biopharmaceuticals Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Non-oncology Biopharmaceuticals Introduction
      • 12.1.4 Roche Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Sanofi
      • 12.2.1 Sanofi Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Non-oncology Biopharmaceuticals Introduction
      • 12.2.4 Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.2.5 Sanofi Recent Development
    • 12.3 Johnson & Johnson
      • 12.3.1 Johnson & Johnson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Non-oncology Biopharmaceuticals Introduction
      • 12.3.4 Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.3.5 Johnson & Johnson Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Non-oncology Biopharmaceuticals Introduction
      • 12.4.4 Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.4.5 Pfizer Recent Development
    • 12.5 Novo Nordisk
      • 12.5.1 Novo Nordisk Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Non-oncology Biopharmaceuticals Introduction
      • 12.5.4 Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.5.5 Novo Nordisk Recent Development
    • 12.6 Novartis
      • 12.6.1 Novartis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Non-oncology Biopharmaceuticals Introduction
      • 12.6.4 Novartis Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.6.5 Novartis Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Non-oncology Biopharmaceuticals Introduction
      • 12.7.4 Merck Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.7.5 Merck Recent Development
    • 12.8 Teva
      • 12.8.1 Teva Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Non-oncology Biopharmaceuticals Introduction
      • 12.8.4 Teva Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.8.5 Teva Recent Development
    • 12.9 Eli Lilly
      • 12.9.1 Eli Lilly Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Non-oncology Biopharmaceuticals Introduction
      • 12.9.4 Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.9.5 Eli Lilly Recent Development
    • 12.10 Bristol-Myers Squibb
      • 12.10.1 Bristol-Myers Squibb Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Non-oncology Biopharmaceuticals Introduction
      • 12.10.4 Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)
      • 12.10.5 Bristol-Myers Squibb Recent Development
    • 12.11 GlaxoSmithKline
    • 12.12 UCB Pharma
    • 12.13 Amgen
    • 12.14 AbbVie
    • 12.15 Takeda
    • 12.16 AstraZeneca
    • 12.17 Mylan
    • 12.18 LEO Pharma
    • 12.19 Boehringer Ingelheim
    • 12.20 Alexion Pharmaceuticals
    • 12.21 Elusys Therapeutics
    • 12.22 Swedish Orphan Biovitrum
    • 12.23 Biogen

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
      In 2018, the global Non-oncology Biopharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Non-oncology Biopharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-oncology Biopharmaceuticals development in United States, Europe and China.

      The key players covered in this study
      Roche
      Sanofi
      Johnson & Johnson
      Pfizer
      Novo Nordisk
      Novartis
      Merck
      Teva
      Eli Lilly
      Bristol-Myers Squibb
      GlaxoSmithKline
      UCB Pharma
      Amgen
      AbbVie
      Takeda
      AstraZeneca
      Mylan
      LEO Pharma
      Boehringer Ingelheim
      Alexion Pharmaceuticals
      Elusys Therapeutics
      Swedish Orphan Biovitrum
      Biogen

      Market segment by Type, the product can be split into
      Biologics
      Biosimilars

      Market segment by Application, split into
      Immunology
      Endocrinology
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Non-oncology Biopharmaceuticals status, future forecast, growth opportunity, key market and key players.
      To present the Non-oncology Biopharmaceuticals development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Non-oncology Biopharmaceuticals are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now